Warning
This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.

3-FEA: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

(newest | oldest) View (newer 50 | ) (20 | 50 | 100 | 250 | 500)

21 July 2025

9 December 2024

30 July 2022

8 February 2021

1 September 2020

9 July 2020

17 January 2020

26 December 2019

19 December 2019

16 May 2019

3 January 2019

25 November 2018

31 July 2018

  • curprev 07:2507:25, 31 July 2018 >BronzeManul 18,101 bytes −146 My extensive research into 3-FEA has not indicated that it causes more significant comedowns/after effects when compared to other amphetamines and in fact it's often reported that it is less significant for those prone to negative stimulant after effects.

30 July 2018

5 July 2018

11 February 2018

1 January 2018

29 December 2017

28 December 2017

  • curprev 23:1323:13, 28 December 2017 >Unity m 18,061 bytes −1 Grammatics
  • curprev 23:1323:13, 28 December 2017 >Unity 18,062 bytes −377 Remove excessive detail in lead. Sort 'Physical effects' to place 'Sedation' & 'Stimulation' on top. Grammatics.
  • curprev 21:4521:45, 28 December 2017 >BronzeManul 18,439 bytes −25 Removed 'Effects section stub' and 'Legality section stub' banner notices as these sections are no longer stubs following an overhaul of the page. 'Legality' was also changed to 'Legal Status' as the section title.
  • curprev 21:4321:43, 28 December 2017 >BronzeManul 18,464 bytes +64 Added and/or section to pharmacology sentence based around 3-FEA being a reuptake inhibitor to note possibility of a releasing agent mechanism of action being the more significant as this is currently an unknown distinction.
  • curprev 21:4021:40, 28 December 2017 >BronzeManul m 18,400 bytes +1 Reordered 'serotonin' and 'norepinephrine' in pharmacology section second paragraph.
  • curprev 21:1921:19, 28 December 2017 >BronzeManul 18,399 bytes +84 Rewrote intro paragraph to better explain similarity to 4-FA and dissimilarity to its close analog 3-FA instead of basing the comparison around 2-FA and 2-FMA.
  • curprev 21:0921:09, 28 December 2017 >BronzeManul 18,315 bytes +287 Added description for 'increased music appreciation' effect with citation needed marker, added description for 'wakefulness' effect, and added description for 'increased music appreciation' effect.
  • curprev 21:0421:04, 28 December 2017 >BronzeManul 18,028 bytes +117 Added 'diarrhea' effect with description and included citation needed marker.
  • curprev 20:5920:59, 28 December 2017 >BronzeManul 17,911 bytes +214 Added description for 'empathy, affection, and sociability enhancement' effect with included citation needed marker.
  • curprev 20:5420:54, 28 December 2017 >BronzeManul m 17,697 bytes +1 Corrected mark-up for 'thought deceleration' effect.
  • curprev 20:5320:53, 28 December 2017 >BronzeManul 17,696 bytes +235 Rewrote part of the description of the competing 'anxiety suppression' and 'anxiety' effects to better reflect prominence during different periods of the substance's effects and added 'thought deceleration' effect along with comparative description.
  • curprev 20:4420:44, 28 December 2017 >BronzeManul 17,461 bytes +206 Expanded description of the competing 'sedation' and 'stimulation' effects to better reflect correlation to dosage and point during the duration of effect of a dose.
  • curprev 20:3920:39, 28 December 2017 >BronzeManul 17,255 bytes +115 Corrected incomplete 'appetite suppression' effect description.
  • curprev 20:3620:36, 28 December 2017 >BronzeManul m 17,140 bytes +188 Further updated 'pupil dilation' effect description and added to after effects section as well.
  • curprev 20:2620:26, 28 December 2017 >BronzeManul 16,952 bytes +163 Rewrote descriptions of 'pupil dilation' and 'teeth grinding' effects to better reflex significance of said effects at various dosage ranges.
  • curprev 20:1420:14, 28 December 2017 >BronzeManul 16,789 bytes +39 Updated description of 'difficulty urinating' effect to reflect correlation to dosage and remove claim of assumed harmlessness as this is not supported nor contested.
  • curprev 19:5819:58, 28 December 2017 >BronzeManul m 16,750 bytes 0 Corrected mark-up for 'stimulatory' text that links to 'stimulation' page.

29 November 2017

  • curprev 21:5621:56, 29 November 2017 >BronzeManul 16,750 bytes −5 Updated description based on early reports and added citation needed tag to said section.
  • curprev 21:3521:35, 29 November 2017 >BronzeManul 16,755 bytes −344 The similarity to fenfluramine is a BIG stretch considering the drastic differences between the fluorine group and the trifluoromethyl group seen in fenfluramine and there is no evidence supporting this claim otherwise.

4 November 2017

25 August 2017

  • curprev 00:1000:10, 25 August 2017 >BronzeManul m 17,070 bytes +18 Corrected 'Federal Analog Act' to 'Federal Analogue Act', did some minor rewording of the United States legality statement, and corrected 'analogue' to 'analog' in UK legality statement.

25 June 2017

6 June 2017

(newest | oldest) View (newer 50 | ) (20 | 50 | 100 | 250 | 500)
Retrieved from "http://psy.st/wiki/3-FEA"